Quantcast

Latest hemoglobin Stories

2011-02-11 21:56:57

American Stroke Association meeting report Silent strokes, which have no immediate symptoms but could cause long-term cognitive and learning deficits, occur in a significant number of severely anemic children, especially those with sickle cell disease, according to research presented at the American Stroke Association's International Stroke Conference 2011. One-quarter to one-third of children with sickle cell disease have evidence of silent strokes in their brains, according to Michael M....

2011-02-11 12:19:00

Abstract 185 Audio and video interviews available at ISC 2011 Multimedia Study Highlights: - Symptomless strokes occur in about 20 percent of children with sickle cell disease when their red blood cell levels severely drop. These silent strokes also occur in about 7 percent of hospitalized children without sickle cell who have severe drops in hemoglobin. - Acute anemic events could help account for the high prevalence of silent strokes in children with sickle cell disease. LOS...

2011-01-20 07:00:00

IRVINE, Calif., Jan. 20, 2011 /PRNewswire/ -- Masimo (Nasdaq: MASI) announced today that a new study demonstrating the clinical accuracy and value of its noninvasive and continuous hemoglobin (SpHb®) monitoring technology breakthrough was presented this week at the Society of Critical Care Medicine (SCCM) Annual Critical Care Congress in San Diego. The largest multi-professional critical care event of the year, the SCCM Annual Congress reflects the latest in...

2011-01-10 14:35:18

New insights from the nano world The mechanism for binding oxygen to metalloporphyrins is a vital process for oxygen-breathing organisms. Understanding how small gas molecules are chemically bound to the metal complex is also important in catalysis or the implementation of chemical sensors. When investigating these binding mechanisms, scientists use porphyrin rings with a central cobalt or iron atom. They coat a copper or silver support surface with these substances. An important...

2010-12-30 13:04:56

Patients with diabetes, kidney disease and anemia who don't respond to treatment with an anti-anemia drug have a higher risk of cardiovascular disease or death, researchers at UT Southwestern Medical Center have found. The results suggest that testing such patients' responsiveness to the drug and keeping blood iron levels a little low might reduce their risk, said Dr. Robert Toto, professor of internal medicine and clinical sciences and a senior author of the study, which appeared in the New...

2010-12-17 07:45:04

(IVANHOE NEWSWIRE)-- No, this is not the title of another Stephen King masterpiece, this is real life. Staphylococcus aureus (staph) bacteria feed on blood. According to researchers, it turns out that these microbial vampires prefer the taste of human blood. They need the iron that's hidden away inside red blood cells to grow and cause infections. Staph favors human hemoglobin "“ the oxygen-carrying protein that contains iron "“ over hemoglobin from other animals. The findings...

290e55d30b3b8ddcca35fdca5614ca971
2010-12-15 16:31:39

Staphylococcus aureus bacteria bind best to human hemoglobin"Staph" bacteria feed on blood. They need the iron that's hidden away inside red blood cells to grow and cause infections. It turns out that these microbial vampires prefer the taste of human blood, Vanderbilt University scientists have discovered.The researchers report in the Dec. 16 issue of Cell Host & Microbe that Staphylococcus aureus (staph) favors human hemoglobin "“ the oxygen-carrying protein that contains iron...

2010-12-07 07:07:00

ORLANDO, Fla., Dec. 7, 2010 /PRNewswire/ -- HemaQuest Pharmaceuticals, Inc. (HemaQuest), a biotechnology company focused on developing small molecule therapeutics to treat hemoglobin-associated diseases, presented encouraging results at the ASH meeting in Orlando, Florida from its first two clinical trials evaluating its lead product candidate, HQK-1001, an orally administered Small Chain Fatty Acid Derivative (SCFAD) in patients with sickle cell disease and beta thalassemia. In the...

2010-12-03 07:07:00

SAN DIEGO, Dec. 3, 2010 /PRNewswire/ -- HemaQuest Pharmaceuticals, Inc. (HemaQuest), a biotechnology company focused on developing small molecule therapeutics to treat hemoglobin-associated diseases, announced the addition of three experienced executives to the management team. John P. Longenecker, Ph.D. was appointed to serve as President, CEO and Director, Richard Ghalie, MD as Chief Medical Officer, and Tamara A. Seymour as Chief Financial Officer. Dr. Longenecker most recently served...

2010-11-23 07:00:00

EXTON, Pa., Nov. 23, 2010 /PRNewswire/ -- BioTrends Research Group, Inc. released ChartTrends®: Renal Anemia in Chronic Kidney Disease Non-Dialysis (CKD-ND), an annual syndicated publication based on patient and laboratory data collected from over 1,000 US CKD-ND patient charts. ChartTrends® compare what physicians self-report about disease management to what actually occurs at the patient level. This report evaluates the management of renal anemia...


Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related